Market Pulse44Neutral

Hims & Hers Health, Inc.Opportunity Rank #18(HIMS) Intrinsic Value & DCF Analysis (2026)

Sector: Healthcare

Current Price

$33.54

Last updated: Jun 23, 2026

Price vs Intrinsic Value

$33.54
Price
$54.08
Intrinsic Value
Undervalued by 61%MOS: $43.26

Fundamental Score

73/100
Bullish

Weighted across 6 signals

Narrative Score

58/100
Improving

No change vs previous

Trend Score

75/100
Strong

As of 2026-06-22

The intrinsic value of Hims & Hers Health, Inc. (HIMS) is estimated at $54.08 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $33.54, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 14.38% long-term growth rate and a 10.76% discount rate, reflecting expected future free cash flow and cost of capital.

The intrinsic value of Hims & Hers Health, Inc. (HIMS) is estimated at $54.08 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $33.54, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 14.38% long-term growth rate and a 10.76% discount rate, reflecting expected future free cash flow and cost of capital.

Valuation Details

$54.08
61.24% upside
20% margin of safety: $43.26
Years: 10Growth Rate: 14.38%
Want to create your own valuation? Create a free account.

Capital Efficiency

Average Quarterly ROIC
0.7%
Cost of Capital (estimated)11%
Value StatusUnderperforming Capital

The company is earning below its required return. This may indicate inefficient use of capital or excess cash that isn't being reinvested.

Complete historical ROIC is available with
.

Fundamental Details

73/100
BullishWeighted across 6 signals
DCF Discount
61.2% discount to price
100
FCF Yield
6.6% trailing FCF yield
100
ROIC vs WACC
ROIC 0.7% vs WACC 11.0% (0.1x)
3
Net Debt / FCF
0.5x net debt to FCF
91
Buybacks
Share count shrinking
80
FCF CAGR (5Y)
208.7% 5Y FCF CAGR
100
Strengths: DCF Discount, FCF Yield. Concerns: ROIC vs WACC.

Narrative Details

58/100
Improving
Vs 6-Month Baseline:Average (53rd pct)Weighted across 6 recent drivers
Trend: StableConfidence: 87%Updated: 5m ago
Sources: 117 (105 News · 12 Analyst)
Drivers(last 30 days)
83 news sentiment+0.8
6 earnings miss-0.0
5 margin pressure+0.0
7 regulatory scrutiny+0.0
Downgrade headlines-0.0
Restructuring-0.0

Trend Details

75/100
StrongAs of 2026-06-22308 daily bars used
3M Relative Strength vs SPY+37.5%
Price vs 50 EMA+24.2%
Distance from 52-Week High-49.3%
Price vs 21 EMA98 · +15.9%
Price vs 50 EMA99 · +24.2%
21 EMA vs 50 EMA91 · +7.2%
3M RS vs SPY100 · +37.5%
6M RS vs SPY16 · -15.0%
Distance from 52W High1 · -49.3%

Investment Coach

Updating... 12d ago
BUYConfidence: 69%
Thesis
Hims & Hers Health, Inc. (HIMS) is significantly undervalued with an estimated fair value over 110% above its current price, supported by strong fundamentals and a bullish narrative. Despite trailing returns relative to its cost of capital, the company shows robust free cash flow growth and effective buybacks.
Key Risk
The key risk is the company's return on invested capital (ROIC) remaining below its weighted average cost of capital (WACC), which could pressure valuation and returns.
Signals To Watch
  • Monitor whether valuation discount remains above 10%.
  • Track ROIC vs WACC spread for sustained improvement.
  • Follow narrative trend for meaningful shifts in the score direction.
Ask the Coach - Available with
Historical Growth Rates
Free Cash Flow- - -Trend CAGR: 72.16%5 Year CAGR (Adjusted): 249.56%

Free Cash Flow (in millions)

TTM2025202420232022202120202019
$491$526$304$100-$19-$29$2-$73

How Intrinziq Estimates Fair Value

Intrinziq estimates Hims & Hers Health, Inc.'s intrinsic value using a discounted cash flow (DCF) model based on free cash flow trends and a market-based discount rate. The model projects future cash flows over ten years and discounts them using a market return assumption to estimate fair value.

Hims & Hers Health, Inc.Healthcare

Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.

Related Articles

Deep dives and valuation takes on HIMS.